These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19879073)

  • 1. Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias.
    Wharton W; Dowling M; Khosropour CM; Carlsson C; Asthana S; Gleason CE
    Maturitas; 2009 Nov; 64(3):182-7. PubMed ID: 19879073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Shumaker SA; Legault C; Rapp SR; Thal L; Wallace RB; Ockene JK; Hendrix SL; Jones BN; Assaf AR; Jackson RD; Kotchen JM; Wassertheil-Smoller S; Wactawski-Wende J;
    JAMA; 2003 May; 289(20):2651-62. PubMed ID: 12771112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
    Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
    JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS).
    Coker LH; Espeland MA; Rapp SR; Legault C; Resnick SM; Hogan P; Gaussoin S; Dailey M; Shumaker SA
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):304-10. PubMed ID: 19932751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.
    Wroolie TE; Kenna HA; Williams KE; Powers BN; Holcomb M; Khaylis A; Rasgon NL
    Am J Geriatr Psychiatry; 2011 Sep; 19(9):792-802. PubMed ID: 21873835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
    Maki PM; Henderson VW
    Climacteric; 2012 Jun; 15(3):256-62. PubMed ID: 22612612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combination estrogen plus progestin hormone treatment on cognition and affect.
    Resnick SM; Maki PM; Rapp SR; Espeland MA; Brunner R; Coker LH; Granek IA; Hogan P; Ockene JK; Shumaker SA;
    J Clin Endocrinol Metab; 2006 May; 91(5):1802-10. PubMed ID: 16522699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
    Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
    PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minireview: effects of different HT formulations on cognition.
    Maki PM
    Endocrinology; 2012 Aug; 153(8):3564-70. PubMed ID: 22673228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y).
    Vaughan L; Espeland MA; Snively B; Shumaker SA; Rapp SR; Shupe J; Robinson JG; Sarto GE; Resnick SM;
    Brain Res; 2013 Jun; 1514():3-11. PubMed ID: 23578696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.
    Espeland MA; Brinton RD; Hugenschmidt C; Manson JE; Craft S; Yaffe K; Weitlauf J; Vaughan L; Johnson KC; Padula CB; Jackson RD; Resnick SM;
    Diabetes Care; 2015 Dec; 38(12):2316-24. PubMed ID: 26486190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study.
    Coker LH; Hogan PE; Bryan NR; Kuller LH; Margolis KL; Bettermann K; Wallace RB; Lao Z; Freeman R; Stefanick ML; Shumaker SA
    Neurology; 2009 Jan; 72(2):125-34. PubMed ID: 19139363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.
    Resnick SM; Coker LH; Maki PM; Rapp SR; Espeland MA; Shumaker SA
    Clin Trials; 2004; 1(5):440-50. PubMed ID: 16279282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone therapy and cognition.
    McCarrey AC; Resnick SM
    Horm Behav; 2015 Aug; 74():167-72. PubMed ID: 25935728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?
    Gleason CE; Dowling NM; Friedman E; Wharton W; Asthana S
    Menopause; 2012 May; 19(5):524-33. PubMed ID: 22207317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study.
    Resnick SM; Espeland MA; Jaramillo SA; Hirsch C; Stefanick ML; Murray AM; Ockene J; Davatzikos C
    Neurology; 2009 Jan; 72(2):135-42. PubMed ID: 19139364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy.
    Resnick SM; Espeland MA; An Y; Maki PM; Coker LH; Jackson R; Stefanick ML; Wallace R; Rapp SR;
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4152-61. PubMed ID: 19850684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.